CFP
RMD icon

Catalyst Financial Partners’s ResMed RMD Stock Holding History

Catalyst Financial Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
1,246
+305
+32% +$63.2K 0.02% 367
2026
Q1 		$211K Buy
941
+93
+11% +$23.2K 0.02% 359
2025
Q4 		$204K Sell
848
-19
-2% -$4.86K 0.02% 316
2025
Q3 		$237K Buy
867
+13
+2% +$3.55K 0.03% 275
2025
Q2 		$220K Buy
+854
New +$204K 0.02% 278

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Catalyst Financial Partners's RMD Position: Q2 2026 in Review

Catalyst Financial Partners increased its ResMed (RMD) stake by 32% in Q2 2026, buying an estimated $63.2K and bringing the position to 1,246 shares worth $243K. The position accounts for 0.02% of the portfolio, ranked #367.

Catalyst Financial Partners first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Catalyst Financial Partners held 1,246 shares of ResMed worth $243K as of Q2 2026.
  • Catalyst Financial Partners bought 305 ResMed shares in Q2 2026, an estimated $63.2K.
  • ResMed made up 0.02% of Catalyst Financial Partners's portfolio in Q2 2026, its #367 holding.
  • Catalyst Financial Partners first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.